Genelux (GNLX) Current Assets (2022 - 2026)
Genelux (GNLX) recorded quarterly Current Assets of $26.8 million in Q1 2026, up 76.83% quarter-over-quarter from $15.1 million in Q4 2025.
Genelux (GNLX) Current Assets (2022 - 2026) Analysis & Trends
Genelux's Current Assets history runs 5 years deep, the most recent figure standing at $26.8 million for Q1 2026.
- In Q1 2026, Current Assets changed N/A year-over-year to $26.8 million; the TTM figure through Mar 2026 stood at $26.8 million (changed N/A YoY), while the FY2025 annual figure was $15.1 million, down 52.04% from the prior year.
- Current Assets was $26.8 million for Q1 2026 at Genelux, up from $15.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $36.0 million in Q3 2024 to a low of $1.9 million in Q4 2022.
- Historically, Current Assets has averaged $24.9 million across 5 years, with a median of $26.8 million in 2026.
- The sharpest annual moves came in 2023 and 2025: Current Assets jumped 1179.23% in 2023, then tumbled 52.04% in 2025.
- A 5-year view of Current Assets shows it stood at $1.9 million in 2022, then surged by 1179.23% to $24.2 million in 2023, then soared by 30.35% to $31.5 million in 2024, then sank by 52.04% to $15.1 million in 2025, then jumped by 76.83% to $26.8 million in 2026.
- The last three Current Assets figures came in at $26.8 million (Q1 2026), $15.1 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 26.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.75 Mn |
| Dec 31, 2025 | 15.13 Mn |
| Sep 30, 2025 | 21.55 Mn |
| Jun 30, 2025 | 29.24 Mn |
| Dec 31, 2024 | 31.55 Mn |
| Sep 30, 2024 | 35.97 Mn |
| Jun 30, 2024 | 34.87 Mn |
| Mar 31, 2024 | 21.20 Mn |
| Dec 31, 2023 | 24.20 Mn |
| Sep 30, 2023 | 31.18 Mn |
| Dec 31, 2022 | 1.89 Mn |